KUMAR, R.; SINGH, S. K.; SINGH, S.; KUMAR , A. Addressing cardio-metabolic risks in type 2 diabetes: evidence-based insights on efpeglenatide. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 14, n. 4, p. 565–582, 2025. DOI: 10.18203/2319-2003.ijbcp20251843. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/5828. Acesso em: 23 oct. 2025.